Table 6.

Sensitivity, Specificity, PPV, and NPV at optimal cutoffs with AUC regarding tumor size (1.1–2 cm)

Gene	Sensitivity	Specificity	PPV	NPV	AUC	95% CI
CDO1	72%	88%	93%	59%	0.80	0.73–0.88
TAC1	70%	70%	83%	52%	0.69	0.60–0.79
SOX17	65%	93%	95%	55%	0.82	0.75–0.89
HOXA7	61%	77%	85%	48%	0.72	0.63–0.81
CDO1, TAC1, SOX17	73%	93%	96%	62%	0.91	0.87–0.97
CDO1, SOX17, HOXA7	74%	93%	96%	63%	0.92	0.87–0.96

Cancer, n = 92; control, n = 43